Regentis Biomaterials Ltd.
RGNT- Exchange
- NYSE
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- SEC CIK
- 0001912966
No open-market purchases or sales by Regentis Biomaterials Ltd. insiders were filed in the last 90 days; 6 institutions reported holding it in 13F filings for Q2 2026, worth $2.98M in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Regentis Biomaterials Ltd. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 3 | 6 | +3 |
| Shares | 551.8K | 845.8K | +293.9K (+53.3%) |
| Value | $1.69M | $2.98M | +$1.30M (+77.0%) |
New holders (4)
Institutions that held Regentis Biomaterials Ltd. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Warberg Asset Management LLC | 86,980 | $306.2K | 0.09% |
| Jane Street Group, LLC | 43,333 | $153.0K | 0.00% |
| Renaissance Technologies LLC | 13,348 | $47.1K | 0.00% |
| Tower Research Capital LLC (TRC) | 11 | $39 | 0.00% |
Sold out (1)
Institutions that held Regentis Biomaterials Ltd. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| AIGH Capital Management LLC | 300,000 | $916.5K |